Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shea

Showing results (201-210 of 248) with videos related to

Pageof 25
Sort By:
Investigational New Drugs|December 20, 2014
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemiasR Tibes, K T McDonagh, L Lekakis, et al.
Blood Advances|October 25, 2019
Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphomaManali Kamdar, Hongli Li, Robert W Chen, et al.
British Journal of Haematology|April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2020
Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple MyelomaSarah A Holstein, Vera J Suman, Kouros Owzar, et al.
Leukemia & Lymphoma|January 21, 2017
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphomaBeata Holkova, Victor Yazbeck, Maciej Kmieciak, et al.
Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.
Life Sciences|September 25, 2002
Study of brain uptake and biodistribution of [11C]toluene in non-human primates and miceM R Gerasimov, R A Ferrieri, W K Schiffer, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Nuclear Medicine and Biology|October 2, 2001
Species differences in [11C]clorgyline binding in brainJ S Fowler, Y S Ding, J Logan, et al.
Pageof 25

Showing results (201-210 of 248) with videos related to

Sort By:
Pageof 25
Investigational New Drugs|December 20, 2014
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemiasR Tibes, K T McDonagh, L Lekakis, et al.
Blood Advances|October 25, 2019
Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphomaManali Kamdar, Hongli Li, Robert W Chen, et al.
British Journal of Haematology|April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2020
Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple MyelomaSarah A Holstein, Vera J Suman, Kouros Owzar, et al.
Leukemia & Lymphoma|January 21, 2017
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphomaBeata Holkova, Victor Yazbeck, Maciej Kmieciak, et al.
Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.
Life Sciences|September 25, 2002
Study of brain uptake and biodistribution of [11C]toluene in non-human primates and miceM R Gerasimov, R A Ferrieri, W K Schiffer, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Nuclear Medicine and Biology|October 2, 2001
Species differences in [11C]clorgyline binding in brainJ S Fowler, Y S Ding, J Logan, et al.
Pageof 25